Document:

EXHIBIT 4.2

 

THE
SECURITIES REPRESENTED BY THIS INSTRUMENT HAVE NOT BEEN REGISTERED UNDER THE
SECURITIES ACT OF 1933, AS AMENDED, OR SECURITIES LAWS OF ANY STATE AND MAY NOT
BE TRANSFERRED, SOLD OR OTHERWISE DISPOSED OF EXCEPT WHILE A REGISTRATION
STATEMENT RELATING THERETO IS IN EFFECT UNDER SUCH ACT AND APPLICABLE STATE
SECURITIES LAWS OR PURSUANT TO AN EXEMPTION FROM REGISTRATION UNDER SUCH ACT OR
SUCH LAWS.

 

THE
SECURITIES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO TRANSFER AND OTHER
RESTRICTIONS SET FORTH IN AN INVESTMENT AGREEMENT, DATED AS OF APRIL 7, 2008,
COPIES OF WHICH ARE ON FILE WITH THE SECRETARY OF THE ISSUER.

 

WARRANT

 

to purchase

 

[  ]

 

Shares of Common
Stock

 

dated as of April 11,
2008

 

WASHINGTON MUTUAL, INC.

a Washington Corporation

 

Issue Date:    

 

1.             Definitions. 
Unless the context otherwise requires, when used herein the following
terms shall have the meanings indicated.

 

“Affiliate” has the
meaning set forth in Section 6.10(a) of the Investment Agreement.

 

“Applicable Price” means
the greater of (A) the greater of the Market Price per share of
outstanding Common Stock on (i) the date on which the Company issues or
sells any Common Stock other than Excluded Stock and (ii) the first date
of the announcement of such issuance or sale and (B) the Reference
Purchase Price.

 

“Appraisal Procedure”
means a procedure whereby two independent appraisers, one chosen by the Company
and one by the Warrantholder (or if there is more than one Warrantholder, a
majority in interest of Warrantholders), shall mutually agree upon the
determinations then the subject of appraisal. 
Each party shall deliver a notice to the other appointing its appraiser
within 15 days after the Appraisal Procedure is invoked.  If within 30 days after appointment of the
two appraisers they are unable to agree upon the amount in question, a third
independent appraiser shall be chosen within 10 days thereafter by the mutual 

 

 

consent of such first two appraisers or, if such first
two appraisers fail to agree upon the appointment of a third appraiser, such
appointment shall be made by the American Arbitration Association, or any
organization successor thereto, from a panel of arbitrators having experience
in the appraisal of the subject matter to be appraised.  The decision of the third appraiser so
appointed and chosen shall be given within 30 days after the selection of such
third appraiser.  If three appraisers
shall be appointed and the determination of one appraiser is disparate from the
middle determination by more than twice the amount by which the other
determination is disparate from the middle determination, then the
determination of such appraiser shall be excluded, the remaining two
determinations shall be averaged and such average shall be binding and
conclusive on the Company and the Warrantholder; otherwise, the average of all
three determinations shall be binding and conclusive on the Company and the
Warrantholder.  The costs of conducting
any Appraisal Procedure shall be borne by the Warrantholder requesting such
Appraisal Procedure, except (A) the fees and expenses of the appraiser
appointed by the Company and any other costs incurred by the Company shall be
borne by the Company and (B) if such Appraisal Procedure shall result in a
determination that is disparate by 5% or more from the Company’s initial
determination, all costs of conducting such Appraisal Procedure shall be borne
by the Company.

 

“Beneficially Own” or “Beneficial Owner” has the meaning set
forth in Section 4.1(f) of the Investment Agreement.

 

“Board of Directors” has
the meaning set forth in Section 2.2(d) of the Investment Agreement.

 

“Board Representative”
has the meaning set forth in Section 4.3 of the Investment Agreement.

 

“Business Combination”
means a merger, consolidation, statutory share exchange or similar transaction
that requires adoption by the Company’s shareholders.

 

“business day”  means any day except Saturday, Sunday and
any day which shall be a legal holiday or a day on which banking institutions
in the State of New York or in the State of Washington generally are authorized
or required by law or other governmental actions to close.

 

“Common Shares” has the
meaning set forth in Section 2.

 

“Capital Stock” means (A) with
respect to any person that is a corporation or company, any and all shares,
interests, participations or other equivalents (however designated) of capital
or capital stock of such person and (B) with respect to any person that is
not a corporation or company, any and all partnership or other equity interests
of such person.

 

 “Common Stock” has the meaning given to it in the recitals of
the Investment Agreement.

 

“Company” has the meaning
set forth in the preamble of the Investment Agreement.

 

 “Company Subsidiary” has the meaning set forth in Section 2.2(a)(2) of
the Investment Agreement.

 

 

“Convertible Preferred Stock”
shall have the meaning set forth in the recitals of the Investment Agreement.

 

“Exchange Act” means the
Securities Exchange Act of 1934, as amended, or any successor statute, and the rules and
regulations promulgated thereunder.

 

“Excluded Stock” means (A) shares
of Common Stock issued by the Company as a stock dividend payable in shares of
Common Stock, or upon any subdivision or split-up of the outstanding shares of
Capital Stock in each case which is subject to Section 13(B), or upon
conversion of shares of Capital Stock (but not the issuance of such Capital
Stock which will be subject to the provisions of Section 13(A)), (B) shares
of Common Stock to be issued to employees, consultants and advisors of the
Company pursuant to options, restricted stock units or other equity-based
awards granted prior to the date of issuance of this Warrant and pursuant to
options, restricted stock units or other equity-based awards granted after the
date of issuance of this Warrant if the exercise price per share of Common
Stock on the date of such grant equals or exceeds the Market Price of a share
of Common Stock on the date of such grant and (C) shares of Common Stock
issued by the Company in connection with a dividend reinvestment, employee or
shareholder stock purchase plan.

 

“Exercise
Approvals” means the collective reference
to the Shareholder Approvals and the Regulatory Approvals.

 

“Exercise Price” means an
amount equal to the lower of (i) an amount equal to 115% of the average
Market Price of the Common Stock during the five trading days following the
public announcement of the results of the Company’s quarter ended March 31,
2008 (it being understood that if the such announcement occurs prior to the
commencement of trading on the New York Stock Exchange, the first trading day
following such announcement shall be the day of such announcement) and (ii) an
amount equal to 115% of the Reference Purchase Price; provided, that such amount shall be
reduced by $0.50 on each six-month anniversary of the date of this Warrant if
the Shareholder Approvals shall not have been obtained prior to such
anniversary, up to a maximum reduction of $2.00.

 

“Expiration Time” has the
meaning set forth in Section 3.

 

“Fundamental Change” means the occurrence of one
of the following:

 

(i) a “person” or “group”
within the meaning of Section 13(d) of the Exchange Act files a
Schedule TO or any schedule, form or report under the Exchange Act disclosing
that such person
or group has become the direct or indirect ultimate Beneficial Owner of common
equity of the Company representing more than 50% of the voting power of the
outstanding Common Stock;

 

(ii) consummation
of any consolidation or merger of the Company or similar transaction or any sale,
lease or other transfer in one transaction or a series of transactions of all
or substantially all of the consolidated assets of the Company and its
subsidiaries, taken as a whole, to any Person other than one of the Company’s
subsidiaries, in each case pursuant to which the Common Stock will be converted
into cash, securities or other property, other than pursuant to a transaction
in which the Persons that Beneficially Owned, directly or indirectly, voting
shares of the Company immediately prior to such transaction Beneficially Own,
directly or indirectly, 

 

 

voting
shares representing a majority of the total voting power of all outstanding
classes of voting shares of the continuing or surviving Person immediately
after the transaction; or

 

(iii) the Company’s
shareholders approve and adopt a plan of liquidation or dissolution of the
Company or a sale of all or substantially all of the Company’s assets.

 

 “Governmental Entities” has the meaning set forth in Section 2.2(e) of
the Investment Agreement.

 

“Group” means a group as
contemplated by Section 13(d)(3) of the Exchange Act.

 

“Investment Agreement”
means the Investment Agreement, dated as of April 7, 2008, between the
Company and the Investors, including all schedules and exhibits thereto.

 

“Investors” has the
meaning set forth in the preamble of the Investment Agreement.

 

“Market Price” means,
with respect to a particular security, on any given day, the last reported sale
price regular way or, in case no such reported sale takes place on such day, the
average of the last closing bid and ask prices regular way, in either case on
the principal national securities exchange on which the applicable securities
are listed or admitted to trading, or if not listed or admitted to trading on
any national securities exchange, (A) the closing sale price for such day
reported by the Nasdaq Stock Market if such security is traded over-the-counter
and quoted in the Nasdaq Stock Market, or (B) if such security is so
traded, but not so quoted, the average of the closing reported bid and ask
prices of such security as reported by the Nasdaq Stock Market or any
comparable system, or (C) if such security is not listed on the Nasdaq
Stock Market or any comparable system, the average of the closing bid and ask
prices as furnished by two members of the National Association of Securities
Dealers, Inc. selected from time to time by the Company for that
purpose.  If such security is not listed
and traded in a manner that the quotations referred to above are available for
the period required hereunder, the Market Price per share of Common Stock shall
be deemed to be the fair value per share of such security as determined in good
faith by the Board of Directors.

 

“New Issuance Price” has
the meaning set forth in Section 3(A)(i).

 

“Ordinary Cash Dividends”
means a regular quarterly cash dividend out of surplus or net profits legally
available therefor (determined in accordance with generally accepted accounting
principles, consistently applied) and consistent with past practice.

 

“person”  has the meaning given to it in Section 3(a)(9) of
the Exchange Act and as used in Sections 13(d)(3) and 14(d)(2) of the
Exchange Act.

 

“Preliminary Fundamental Change”
means, with respect to the Company, (A) the execution of definitive
documentation for a transaction or (B) the recommendation that
shareholders tender in response to a tender or exchange offer, that could
reasonably result in a Fundamental Change upon consummation.

 

“Pro Rata Repurchases”
means any purchase of shares of Common Stock by the Company or any Affiliate
thereof pursuant to any tender offer or exchange offer subject to 

 

 

Section 13(e) of the Exchange Act, or
pursuant to any other offer available to substantially all holders of Common
Stock, whether for cash, shares of Capital Stock of the Company, other
securities of the Company, evidences of indebtedness of the Company or any
other person or any other property (including, without limitation, shares of
Capital Stock, other securities or evidences of indebtedness of a Company Subsidiary),
or any combination thereof, effected while this Warrant is outstanding; provided, however,
that “Pro Rata Repurchase” shall not include any purchase of shares by the
Company or any Affiliate thereof made in accordance with the requirements of Rule 10b-18
as in effect under the Exchange Act.  The
“Effective Date” of a Pro Rata
Repurchase shall mean the date of acceptance of shares for purchase or exchange
under any tender or exchange offer which is a Pro Rata Repurchase or the date
of purchase with respect to any Pro Rata Repurchase that is not a tender or
exchange offer.

 

“Regulatory Approvals”
with respect to the Warrantholder, means the receipt of approvals and
authorizations of, filings and registrations with, notifications to, or
expiration or termination of any applicable waiting period under, the
Hart-Scott-Rodino Antitrust Improvements Act of 1976 or the competition or
merger control laws of other jurisdictions, in each case necessary to the
extent necessary to permit such Warrantholder to exercise this Warrant for a
Share and to own such Share of Common Stock.

 

“Reference Purchase Price”
has the meaning set forth in Section 1.2(b) of the Investment
Agreement.

 

“Reset Price” has the meaning set forth in Section 3(A)(i).

 

“SEC” means the U.S.
Securities and Exchange Commission.

 

“Securities Act” means
the Securities Act of 1933, as amended, or any successor statute, and the rules and
regulations promulgated thereunder.

 

“Shares” has the meaning
set forth in Section 2.

 

“Shareholder Approvals”
means all shareholder approvals necessary to (A) approve the exercise of
this Warrant for a Share for purposes of Section 312.03 of the NYSE Listed
Company Manual, and (B) amend the Articles to increase the number of
authorized shares of Common Stock to at least such number as shall be
sufficient to permit the exercise of this Warrant for a Share.

 

 “Subsidiary” has the meaning set forth in Section 2.2(a)(2) of
the Investment Agreement.

 

“Underlying Security Price”
has the meaning set forth in Section 3(A)(i).

 

“Voting Securities” has
the meaning set forth in Section 4.1(f) of the Investment Agreement.

 

“Warrantholder” has the
meaning set forth in Section 2.

 

“Warrants” means this
Warrant, issued pursuant to the Investment Agreement.

 

 

2.             Number of Shares; Exercise Price. 
This certifies that, for value received, [NAME OF HOLDER], its
affiliates or its registered assigns (the “Warrantholder”)
is entitled, upon the terms and subject to the conditions hereinafter set
forth, to acquire from the Company, in whole or in part, after the receipt of
Exercise Approvals, up to an aggregate of [·] fully paid and nonassessable shares of
Common Stock, no par value, of the Company (the “Common Shares”), at a
purchase price per Common Share equal to the Exercise Price.  The number of Common Shares (the “Shares”) and the Exercise Price are
subject to adjustment as provided herein, and all references to “Common Stock”
and “Exercise Price” herein shall be deemed to include any such adjustment or
series of adjustments.

 

3.             Exercise of Warrant; Term. 
Subject to Section 2, to the extent permitted by applicable laws
and regulations, the right to purchase the Shares represented by this Warrant
is exercisable, in whole or in part by the Warrantholder, at any time or from
time to time after 9:00 a.m., New York City time, on the date hereof, but
in no event later than 11:59 p.m., New York City time, on the fifth
anniversary of the date of issuance of the Warrant (the “Expiration
Time”), by (A) the surrender of this Warrant and Notice of
Exercise annexed hereto, duly completed and executed on behalf of the
Warrantholder, at the office of the Company in Seattle, Washington (or such
other office or agency of the Company in the United States as it may designate
by notice in writing to the Warrantholder at the address of the Warrantholder
appearing on the books of the Company), and (B) payment of the Exercise
Price for the Shares thereby purchased at the election of the Warrantholder in
one of the following manners:

 

(i)            by tendering in cash, by certified or
cashier’s check or by wire transfer payable to the order of the Company, or

 

(ii)           by having the Company withhold shares of Common Stock
issuable upon exercise of the Warrant equal in value to the aggregate Exercise
Price as to which this Warrant is so exercised based on the Market Price of the
Common Stock on the trading day prior to the date on which this Warrant and the
Notice of Exercise are delivered to the Company.

 

If the Warrantholder does not exercise this Warrant in
its entirety, the Warrantholder will be entitled to receive from the Company
within a reasonable time, and in any event not exceeding three business days, a
new warrant in substantially identical form for the purchase of that number of
Shares equal to the difference between the number of Shares subject to this
Warrant and the number of Shares as to which this Warrant is so exercised.
Notwithstanding anything in this Warrant to the contrary, the Warrantholder
hereby acknowledges and agrees that its exercise of this Warrant for Shares is
subject to the condition that it will have first received the Shareholder
Approvals.

 

4.             Issuance of Shares; Authorization;
Listing.  Certificates for Shares issued upon exercise
of this Warrant will be issued in such name or names as the Warrantholder may
designate and will be delivered to such named person or persons within a
reasonable time, not to exceed three business days after the date on which this
Warrant has been duly exercised in accordance with the terms of this Warrant.  The Company hereby represents and warrants
that any Shares issued upon the exercise of this Warrant in accordance with the
provisions of Section 3 will, upon receipt of the Shareholder Approvals,
be duly and validly authorized and issued, 

 

 

fully paid and nonassessable and free from all taxes,
liens and charges (other than liens or charges created by the Warrantholder or
taxes in respect of any transfer occurring contemporaneously therewith).  The Company agrees that the Shares so issued
will be deemed to have been issued to the Warrantholder as of the close of
business on the date on which this Warrant and payment of the Exercise Price
are delivered to the Company in accordance with the terms of this Warrant,
notwithstanding that the stock transfer books of the Company may then be closed
or certificates representing such Shares may not be actually delivered on such
date.  Subject to receipt of Exercise
Approvals, the Company will at all times reserve and keep available, out of its
authorized but unissued Common Stock, solely for the purpose of providing for
the exercise of this Warrant, the aggregate number of shares of Common Stock
issuable upon exercise of this Warrant. 
The Company will (A) procure, at its sole expense, the listing of
the Shares and other securities issuable upon exercise of this Warrant, subject
to issuance or notice of issuance on all stock exchanges on which the Common
Stock are then listed or traded and (B) maintain the listing of such
Shares after issuance.  The Company will
use reasonable best efforts to ensure that the Shares may be issued without
violation of any applicable law or regulation or of any requirement of any
securities exchange on which the Shares are listed or traded.

 

5.             No Fractional Shares or Scrip. 
No fractional Shares or scrip representing fractional Shares shall be
issued upon any exercise of this Warrant. 
In lieu of any fractional Share to which the Warrantholder would
otherwise be entitled, the Warrantholder shall be entitled to receive a cash
payment equal to the Market Price of the Common Stock less the Exercise Price
for such fractional share.

 

6.             No Rights as Shareholders; Transfer Books. 
This Warrant does not entitle the Warrantholder to any voting rights or
other rights as a shareholder of the Company prior to the date of exercise
hereof.  The Company will at no time
close its transfer books against transfer of this Warrant in any manner which
interferes with the timely exercise of this Warrant.

 

7.             Charges, Taxes and Expenses. 
Issuance of certificates for Shares to the Warrantholder upon the
exercise of this Warrant shall be made without charge to the Warrantholder for
any issue or transfer tax or other incidental expense in respect of the
issuance of such certificates, all of which taxes and expenses shall be paid by
the Company.

 

8.             Transfer/Assignment.

 

(A)          Subject to compliance with clause (B) of
this Section 8, without obtaining the consent of the Company to assign or
transfer this Warrant, this Warrant and all rights hereunder are transferable,
in whole or in part, upon the books of the Company by the registered holder
hereof in person or by duly authorized attorney, and a new warrant shall be
made and delivered by the Company, of the same tenor and date as this Warrant
but registered in the name of one or more transferees, upon surrender of this
Warrant, duly endorsed, to the office or agency of the Company described in Section 2.  All expenses (other than stock transfer
taxes) and other charges payable in connection with the preparation, execution
and delivery of the new warrants pursuant to this Section 8 shall be paid
by the Company.

 

 

(B)           Notwithstanding the foregoing, this
Warrant and any rights hereunder, and any Shares issued upon exercise of this
Warrant, shall be subject to the applicable restrictions as set forth in Section 4.2
of the Investment Agreement.

 

(C)           If and for so long as required by the
Investment Agreement, this Warrant Certificate shall contain a legend as set
forth in Section 4.4 of the Investment Agreement.

 

9.             Exchange and Registry of Warrant. 
This Warrant is exchangeable, upon the surrender hereof by the
Warrantholder to the Company, for a new warrant or warrants of like tenor and
representing the right to purchase the same aggregate number of Shares.  The Company shall maintain a registry showing
the name and address of the Warrantholder as the registered holder of this
Warrant.  This Warrant may be surrendered
for exchange or exercise, in accordance with its terms, at the office of the
Company, and the Company shall be entitled to rely in all respects, prior to
written notice to the contrary, upon such registry.

 

10.           Loss, Theft, Destruction or Mutilation of
Warrant.  Upon receipt by the Company of evidence
reasonably satisfactory to it of the loss, theft, destruction or mutilation of
this Warrant, and in the case of any such loss, theft or destruction, upon
receipt of an indemnity or security reasonably satisfactory to the Company, or,
in the case of any such mutilation, upon surrender and cancellation of this
Warrant, the Company shall make and deliver, in lieu of such lost, stolen,
destroyed or mutilated Warrant, a new Warrant of like tenor and representing
the right to purchase the same aggregate number of Shares as provided for in
such lost, stolen, destroyed or mutilated Warrant.

 

11.           Saturdays, Sundays, Holidays, etc. 
If the last or appointed day for the taking of any action or the
expiration of any right required or granted herein shall not be a business day,
then such action may be taken or such right may be exercised on the next
succeeding day that is a business day.

 

12.           Rule 144 Information. 
The Company covenants that it will use its reasonable best efforts to
timely file all reports and other documents required to be filed by it under
the Securities Act and the Exchange Act and the rules and regulations
promulgated by the SEC thereunder (or, if the Company is not required to file
such reports, it will, upon the request of any Warrantholder, make publicly
available such information as necessary to permit sales pursuant to Rule 144
or Regulation S under the Securities Act), and it will use reasonable best
efforts to take such further action as any Warrantholder may reasonably
request, in each case to the extent required from time to time to enable such
holder to sell the Warrants without registration under the Securities Act
within the limitation of the exemptions provided by (A) Rule 144 or
Regulation S under the Securities Act, as such rules may be amended from
time to time, or (B) any similar rule or regulation hereafter adopted
by the SEC.  Upon the written request of
any Warrantholder, the Company will deliver to such Warrantholder a written
statement that it has complied with such requirements.

 

13.           Adjustments and Other Rights. 
The Exercise Price and the number of Shares issuable upon exercise of
this Warrant shall be subject to adjustment from time to time as follows; provided that no single event shall be
subject to adjustment under more than one subsection of this Section 13 so
as to result in duplication:

 

 

(A)          Common Stock Issued at Less than the
Applicable Price.

 

(i)            If prior to the date that is eighteen
months after the date of this Warrant, (i) the Company issues or sells, or
agrees to issue or sell, more than $500 million of equity or equity-linked
securities other than Excluded Stock for consideration per share (the “New Issuance Price”) less than the
Applicable Price, or (ii) there occurs any Fundamental Change in which the
Underlying Security Price (together with the New Issuance Price, the “Reset Price”) is less than the Applicable
Price, then the Exercise Price in effect immediately prior to each such
issuance or sale will immediately be reduced to the Reset Price. In such event,
the number of Shares issuable upon the exercise of this Warrant shall be increased
to the number obtained by dividing (x) the product of (1) the number
of Shares issuable upon the exercise of this Warrant before such adjustment and
(2) the Exercise Price in effect immediately prior to the issuance or sale
giving rise to this adjustment, by (y) the new Exercise Price determined
in accordance with the immediately preceding sentence.

 

(ii)           For the purposes of any adjustment of the
Exercise Price and the number of Shares issuable upon exercise of this Warrant
pursuant to this Section 13(A), the following provisions shall be
applicable:

 

(1)           In the case of the issuance or sale of
equity or equity-linked securities for cash, the amount of the consideration
received by the Company shall be deemed to be the amount of the gross cash
proceeds received by the Company for such securities before deducting therefrom
any discounts or commissions allowed, paid or incurred by the Company for any
underwriting or otherwise in connection with the issuance and sale thereof.

 

(2)           In the case of the issuance or sale of
equity or equity-linked securities (otherwise than upon the conversion of
shares of Capital Stock or other securities of the Company) for a consideration
in whole or in part other than cash, including securities acquired in exchange
therefor (other than securities by their terms so exchangeable), the
consideration other than cash shall be deemed to be the fair value thereof as
determined by the Board of Directors, before deducting therefrom any discounts
or commissions allowed, paid or incurred by the Company for any underwriting or
otherwise in connection with the issuance and sale thereof, provided, however,
that such fair value as determined by the Board of Directors shall not exceed
the Applicable Price.

 

(3)           In the case of the issuance of (i) options,
warrants or other rights to purchase or acquire equity or equity-linked
securities (whether or not at the time exercisable) or (i) securities by
their terms convertible into or exchangeable for equity or equity-linked
securities (whether or not at the time so convertible or exchangeable) or
options, warrants or rights to purchase such convertible or exchangeable
securities (whether or not at the time exercisable):

 

(a)           The aggregate maximum number of securities deliverable
upon exercise of such options, warrants or other rights to purchase or 

 

 

acquire equity or
equity-linked securities shall be deemed to have been issued at the time such
options, warrants or rights are issued and for a consideration equal to the
consideration (determined in the manner provided in Section 13(A)(i)), if
any, received by the Company upon the issuance or sale of such options,
warrants or rights plus the minimum purchase price provided in such options,
warrants or rights for the equity or equity-linked securities covered thereby.

 

(b)           The aggregate maximum number of shares of equity or
equity-linked securities deliverable upon conversion of or in exchange for any
such convertible or exchangeable securities, or upon the exercise of options,
warrants or other rights to purchase or acquire such convertible or
exchangeable securities and the subsequent conversion or exchange thereof,
shall be deemed to have been issued at the time such securities were issued or
such options, warrants or rights were issued and for a consideration equal to
the consideration, if any, received by the Company for any such securities and
related options, warrants or rights (excluding any cash received on account of
accrued interest or accrued dividends), plus the additional consideration (in each
case, determined in the manner provided in Section 13(A)(i) and
(ii)), if any, to be received by the Company upon the conversion or exchange of
such securities, or upon the exercise of any related options, warrants or
rights to purchase or acquire such convertible or exchangeable securities and
the subsequent conversion or exchange thereof.

 

(c)           On any change in the number of shares of equity or
equity-linked securities deliverable upon exercise of any such options,
warrants or rights or conversion or exchange of such convertible or
exchangeable securities or any change in the consideration to be received by
the Company upon such exercise, conversion or exchange, but excluding changes
resulting from the anti-dilution provisions thereof (to the extent comparable
to the anti-dilution provisions contained herein), the Exercise Price and the
number of Shares issuable upon exercise of this Warrant as then in effect shall
forthwith be readjusted to such Exercise Price and number of Shares as would
have been obtained had an adjustment been made upon the issuance or sale of
such options, warrants or rights not exercised prior to such change, or of such
convertible or exchangeable securities not converted or exchanged prior to such
change, upon the basis of such change.

 

(d)           On the expiration or cancellation of any such options,
warrants or rights (without exercise), or the termination of the right to
convert or exchange such convertible or exchangeable securities (without
exercise), if the Exercise Price and the number of Shares issuable upon
exercise of this Warrant shall have been adjusted upon the issuance or sale
thereof, the Exercise Price and the number of Shares issuable upon exercise of
this Warrant shall forthwith be readjusted to such Exercise 

 

 

Price and number of
Shares as would have been obtained had an adjustment been made upon the
issuance or sale of such options, warrants, rights or such convertible or
exchangeable securities on the basis of the issuance of only the number of
shares of Common Stock actually issued upon the exercise of such options,
warrants or rights, or upon the conversion or exchange of such convertible or
exchangeable securities.

 

(e)           If the Exercise Price and the number of Shares
issuable upon exercise of this warrant shall have been adjusted upon the
issuance or sale of any such options, warrants, rights or convertible or
exchangeable securities, no further adjustment of the Exercise Price and the
number of Shares issuable upon exercise of this Warrant shall be made for the actual
issuance of Common Stock upon the exercise, conversion or exchange thereof; provided, however,
that no increase in the Exercise Price or reduction in the number of Shares
issuable upon exercise of this Warrant shall be made pursuant to subclauses (1) or
(2) of this Section 13(A)(iii).

 

(B)           Stock Splits, Subdivisions,
Reclassifications or Combinations.  If the
Company shall (i) declare a dividend or make a distribution on its Common
Stock in shares of Common Stock, (ii) subdivide or reclassify the outstanding
shares of Common Stock into a greater number of shares, or (iii) combine
or reclassify the outstanding Common Stock into a smaller number of shares, the
number of Shares issuable upon exercise of this Warrant at the time of the
record date for such dividend or distribution or the effective date of such
subdivision, combination or reclassification shall be proportionately adjusted
so that the Warrantholder after such date shall be entitled to purchase the
number of shares of Common Stock which such holder would have owned or been
entitled to receive after such date had this Warrant been exercised immediately
prior to such date.  In such event, the
Exercise Price in effect at the time of the record date for such dividend or
distribution or the effective date of such subdivision, combination or
reclassification shall be adjusted to the number obtained by dividing (x) the
product of (1) the number of Shares issuable upon the exercise of this
Warrant before such adjustment and (2) the Exercise Price in effect
immediately prior to the issuance giving rise to this adjustment by (y) the
new number of Shares issuable upon exercise of the Warrant determined pursuant
to the immediately preceding sentence.

 

(C)           Other Distributions. 
In case the Company shall fix a record date for the making of a
distribution to all holders of shares of its Common Stock (i) of shares of
any class other than its Common Stock, (ii) of evidence of indebtedness of
the Company or any Company Subsidiary, (iii) of assets (excluding Ordinary
Cash Dividends, and dividends or distributions referred to in Section 13(B)),
or (iv) of rights or warrants (excluding those referred to in Section 13(B)),
in each such case, the Exercise Price in effect prior thereto shall be reduced
immediately thereafter to the price determined by dividing (x) an amount
equal to the difference resulting from (1) the number of shares of Common
Stock outstanding on such record date multiplied by the Exercise Price per
Share on such record date, less (2) the fair market value (as reasonably
determined by the Board of Directors) of said shares or evidences of
indebtedness or assets or rights or warrants to be so distributed, by (y) the
number of shares of Common Stock outstanding on such record date; such
adjustment shall be made successively whenever such a record date is
fixed.  In such 

 

 

event, the number of Shares issuable upon the exercise
of this Warrant shall be increased to the number obtained by dividing (x) the
product of (1) the number of Shares issuable upon the exercise of this
Warrant before such adjustment, and (2) the Exercise Price in effect
immediately prior to the issuance giving rise to this adjustment by (y) the
new Exercise Price determined in accordance with the immediately preceding
sentence.  In the event that such
distribution is not so made, the Exercise Price and the number of Shares
issuable upon exercise of this Warrant then in effect shall be readjusted,
effective as of the date when the Board of Directors determines not to
distribute such shares, evidences of indebtedness, assets, rights or warrants,
as the case may be, to the Exercise Price that would then be in effect and the
number of Shares that would then be issuable upon exercise of this Warrant if
such record date had not been fixed.

 

(D)          Certain Repurchases of Common Stock. 
In case the Company effects a Pro Rata Repurchase of Common Stock, then
the Exercise Price shall be reduced to the price determined by multiplying the
Exercise Price in effect immediately prior to the effective date of such Pro
Rata Repurchase by a fraction of which the numerator shall be (i) the
product of (x) the number of shares of Common Stock outstanding
immediately before such Pro Rata Repurchase and (y) the Market Price of a
share of Common Stock on the trading day immediately preceding the first public
announcement by the Company or any of its Affiliates of the intent to effect
such Pro Rata Repurchase, minus (ii) the aggregate purchase price of the
Pro Rata Repurchase, and of which the denominator shall be the product of (i) the
number of shares of Common Stock outstanding immediately prior to such Pro Rata
Repurchase minus the number of shares of Common Stock so repurchased and (ii) the
Market Price per share of Common Stock on the trading day immediately preceding
the first public announcement of such Pro Rata Repurchase.  In such event, the number of shares of Common
Stock issuable upon the exercise of this Warrant shall be increased to the
number obtained by dividing (x) the product of (1) the number of
Shares issuable upon the exercise of this Warrant before such adjustment, and (2) the
Exercise Price in effect immediately prior to the Pro Rata Repurchase giving
rise to this adjustment by (y) the new Exercise Price determined in
accordance with the immediately preceding sentence.

 

(E)           Business Combinations. 
Subject to Section 14 of this Warrant, in case of any Business
Combination or reclassification of Common Stock (other than a reclassification
of Common Stock referred to in Section 13(B)), any Shares issued or
issuable upon exercise of this Warrant after the date of such Business
Combination or reclassification, shall be exchangeable for the number of shares
of stock or other securities or property (including cash) to which the Common
Stock issuable (at the time of such Business Combination or reclassification)
upon exercise of this Warrant immediately prior to such Business Combination or
reclassification would have been entitled upon such Business Combination or
reclassification; and in any such case, if necessary, the provisions set forth
herein with respect to the rights and interests thereafter of the Warrantholder
shall be appropriately adjusted so as to be applicable, as nearly as may
reasonably be, to any shares of stock or other securities or property
thereafter deliverable on the exercise of this Warrant.  In determining the kind and amount of stock,
securities or the property receivable upon consummation of such Business
Combination, if the holders of Common Stock have the right to elect the kind or
amount of consideration receivable upon consummation of such Business
Combination, then the Warrantholder shall have the right to make a similar
election upon exercise of this Warrant with respect to the number of shares of
stock or other securities or property which the Warrantholder will receive upon
exercise of this Warrant.

 

 

(F)           Rounding
of Calculations; Minimum Adjustments. 
All calculations under this Section 13 shall be made to the nearest
one-tenth (1/10th) of a cent or to the nearest one-hundredth (1/100th) of a
share, as the case may be.  Any provision
of this Section 13 to the contrary notwithstanding, no adjustment in the
Exercise Price or the number of Shares into which this Warrant is exercisable
shall be made if the amount of such adjustment would be less than $0.01 or
one-tenth (1/10th) of a share of Common Stock, but any such amount shall be
carried forward and an adjustment with respect thereto shall be made at the
time of and together with any subsequent adjustment which, together with such
amount and any other amount or amounts so carried forward, shall aggregate
$0.01 or 1/10th of a share of Common Stock, or more.

 

(G)           Timing
of Issuance of Additional Common Stock Upon Certain Adjustments.  In any case in which the provisions of this Section 13
shall require that an adjustment shall become effective immediately after a
record date for an event, the Company may defer until the occurrence of such
event (i) issuing to the Warrantholder of this Warrant exercised after
such record date and before the occurrence of such event the additional shares
of Common Stock issuable upon such exercise by reason of the adjustment
required by such event over and above the shares of Common Stock issuable upon
such exercise before giving effect to such adjustment and (ii) paying to
such Warrantholder any amount of cash in lieu of a fractional share of Common
Stock; provided, however, that the Company upon request
shall deliver to such Warrantholder a due bill or other appropriate instrument
evidencing such Warrantholder’s right to receive such additional shares, and
such cash, upon the occurrence of the event requiring such adjustment.

 

(H)          Adjustment
for Unspecified Actions.  If the
Company takes any action affecting the Common Stock, other than actions
described in this Section 13, which in the opinion of the Board of
Directors would materially adversely affect the exercise rights of the
Warrantholder, the Exercise Price for the Warrant and/or the number of Shares
received upon exercise of the Warrant shall be adjusted for the Warrantholder’s
benefit, to the extent permitted by law, in such manner, and at such time, as
such Board of Directors after consultation with the Warrantholder shall
reasonably determine to be equitable in the circumstances.  Failure of the Board of Directors to provide
for any such adjustment will be evidence that the Board of Directors has
determined that it is equitable to make no such adjustments in the
circumstances.

 

(I)            Statement
Regarding Adjustments.  Whenever the
Exercise Price or the number of Shares into which this Warrant is exercisable
shall be adjusted as provided in Section 13, the Company shall forthwith
file at the principal office of the Company a statement showing in reasonable
detail the facts requiring such adjustment and the Exercise Price that shall be
in effect and the number of Shares into which this Warrant shall be exercisable
after such adjustment, and the Company shall also cause a copy of such
statement to be sent by mail, first class postage prepaid, to each
Warrantholder at the address appearing in the Company’s records.

 

(J)            Notice
of Adjustment Event.  In the event
that the Company shall propose to take any action of the type described in this
Section 13 (but only if the action of the type described in this Section 13
would result in an adjustment in the Exercise Price or the number of Shares
into which this Warrant is exercisable or a change in the type of securities or
property to be delivered upon exercise of this Warrant), the Company shall give
notice to the Warrantholder, in the 

 

 

manner set forth in Section 13(I), which notice
shall specify the record date, if any, with respect to any such action and the
approximate date on which such action is to take place.  Such notice shall also set forth the facts
with respect thereto as shall be reasonably necessary to indicate the effect on
the Exercise Price and the number, kind or class of shares or other securities
or property which shall be deliverable upon exercise of this Warrant.  In the case of any action which would require
the fixing of a record date, such notice shall be given at least 10 days prior
to the date so fixed, and in case of all other action, such notice shall be
given at least 15 days prior to the taking of such proposed action.  Failure to give such notice, or any defect
therein, shall not affect the legality or validity of any such action.

 

(K)          No
Impairment.  The Company will not, by
amendment of its articles of incorporation or through any reorganization,
transfer of assets, consolidation, merger, dissolution, issue or sale of
securities or any other voluntary action, avoid or seek to avoid the observance
or performance of any of the terms to be observed or performed hereunder by the
Company, but will at all times in good faith assist in the carrying out of all
the provisions of this Warrant and in taking of all such action as may be
necessary or appropriate in order to protect the rights of the Warrantholder.

 

(L)           Proceedings
Prior to Any Action Requiring Adjustment. 
As a condition precedent to the taking of any action which would require
an adjustment pursuant to this Section 13, the Company shall take any
action which may be necessary, including obtaining regulatory, New York Stock
Exchange or shareholder approvals or exemptions, in order that the Company may
thereafter validly and legally issue as fully paid and nonassessable all shares
of Common Stock  that the Warrantholder
is entitled to receive upon exercise of this Warrant pursuant to this Section 13.

 

(M)         Adjustment
Rules.  Any adjustments pursuant to
this Section 13 shall be made successively whenever an event referred to
herein shall occur.  If an adjustment in
Exercise Price made hereunder would reduce the Exercise Price to an amount
below par value of the Common Stock, then such adjustment in Exercise Price
made hereunder shall reduce the Exercise Price to the par value of the Common
Stock.

 

14.           Fundamental
Change.  Upon the occurrence of a
Preliminary Fundamental Change or Fundamental Change, and by delivering written
notice thereof to the Company, the Warrantholder may cause the Company to
purchase any Warrant, in whole or in part, acquired hereunder that the
Warrantholder then holds, at the higher of (i) the fair market value of
the Warrant and (ii) a valuation based on a computation of the option
value of the Warrant using Black-Scholes calculation methods and making the
assumptions described in the Black-Scholes methodology described in Exhibit A.  Payment by the Company to the Warrantholder
of such purchase price shall be due upon the occurrence of the Fundamental
Change, subject to the mechanics described in the last paragraph of Exhibit A.  At the election of the Company, all or any
portion of such purchase price may be paid in cash or Common Shares valued at
the Market Price of a share of Common Stock as of (A) the last trading day
prior to the date on which this payment occurs or (B) the first date of
the announcement of such Preliminary Fundamental Change or Fundamental Change
(whichever is less), so long as such payment does not cause either (i) the
Company to fail to comply with applicable New York Stock Exchange requirements
or the requirements of any other Governmental Entities or (ii) the
Warrantholder to own 25% or 

 

 

more of the Company’s outstanding Common Shares or
otherwise be in violation of the limitations set forth in 12 C.F.R. Part 574
(or any successor provision).  To the
extent that a payment in Common Shares would cause the Company to fail to
comply with New York Stock Exchange rules or result in the Warrantholder
being in violation of such limitations, once the maximum number of Common
Shares that would not result in the contravention of such rules has been
paid, the remainder of such purchase price may be paid, at the option of the
Company and provided the issuance of securities would not cause the
Warrantholder to be in violation of such limitations, in the form of cash or
equity securities of the Company having a fair market value on a
fully-distributed basis equal to the value (determined as provided above) of
the Common Shares that would have been issued to the Warrantholder in the
absence of the limitation described in this sentence.  The Company agrees that it will not take any
action resulting in a Preliminary Fundamental Change or Fundamental Change in
the absence of definitive documentation providing for such election right of
the Warrantholder pursuant to this Section 14.  Subject to Section 4.2(c) of the
Investment Agreement, the Warrantholder shall not be restricted from engaging
in any hedging or derivative program reasonably necessary in the opinion of the
Warrantholder to secure the option value of this Warrant so adjusted.

 

15.           Exchange
for Convertible Preferred Stock.  At
any time prior to the receipt of Exercise Approvals, the Warrantholder may
cause the Company to exchange this Warrant for a number of shares of Convertible
Preferred Stock equal to the product of (i) the value of this Warrant
based on the higher of (A) the fair market value of the Warrant and (B) a
computation of the option value of the Warrant using the Black-Scholes
calculation methods and making the assumptions described in the Black-Scholes
methodology described in Exhibit A divided by (ii) the lower
of (A) $100,000 or (B) the fair market value of a share of
Convertible Preferred Stock, provided that
the Company shall pay cash to the Warrantholder in lieu of any fractional
shares of Convertible Preferred Stock. 
The Company will at all times reserve and keep available, out of its
authorized preferred stock, a sufficient number of shares of preferred stock for
the purpose of providing for the exchange of this Warrant for shares of
Convertible Preferred Stock.  The Company
shall initially calculate any fair market value required to be calculated
pursuant to Section 14 and this Section 15.  If the Warrantholder does not accept the
Company’s calculation of fair market value and the Warrantholder and the
Company are unable to agree on fair market value, the Appraisal Procedure shall
be used to determine fair market value.

 

16.           Governing
Law.  This Warrant shall be binding
upon any successors or assigns of the Company. 
This Warrant shall constitute a contract under the laws of New York and
for all purposes shall be construed in accordance with and governed by the laws
of New York, without giving effect to the conflict of laws principles.

 

17.           Attorneys’
Fees.  In any litigation, arbitration
or court proceeding between the Company and the Warrantholder as the holder of
this Warrant relating hereto, the prevailing party shall be entitled to
reasonable attorneys’ fees and expenses incurred in enforcing this Warrant.

 

18.           Amendments.  This Warrant may be amended and the
observance of any term of this Warrant may be waived only with the written
consent of the Company and the Warrantholder.

 

 

19.           Notices.  All notices hereunder shall be in writing and
shall be effective (A) on the day on which delivered if delivered
personally or transmitted by telex or telegram or telecopier with evidence of
receipt, (B) one business day after the date on which the same is
delivered to a nationally recognized overnight courier service with evidence of
receipt, or (C) five business days after the date on which the same is
deposited, postage prepaid, in the U.S. mail, sent by certified or registered
mail, return receipt requested, and addressed to the party to be notified at
the address indicated below for the Company, or at the address for the
Warrantholder set forth in the registry maintained by the Company pursuant to Section 9,
or at such other address and/or telecopy or telex number and/or to the
attention of such other person as the Company or the Warrantholder may
designate by ten-day advance written notice.

 

20.           Prohibited
Actions.  The Company agrees that it
will not take any action which would entitle the Warrantholder to an adjustment
of the Exercise Price if the total number of shares of Common Stock issuable
after such action upon exercise of this Warrant, together with all shares of
Common Stock then outstanding and all shares of Common Stock then issuable upon
the exercise of all outstanding options, warrants, conversion and other rights,
would exceed the total number of shares of Common Stock then authorized by its
articles of incorporation.

 

21.           Entire
Agreement.  This Warrant and the
forms attached hereto, and the Investment Agreement, contain the entire
agreement between the parties with respect to the subject matter hereof and
supersede all prior and contemporaneous arrangements or undertakings with
respect thereto.

 

[Remainder
of page intentionally left blank]

 

 

IN WITNESS WHEREOF, the Company has caused
this Warrant to be duly
executed by a duly authorized officer.

 

Dated:
[              ]

 

 

	
   

  	
  WASHINGTON MUTUAL, INC.

  
	
   

  	
   

  
	
   

  	
   

  
	
   

  	
  By:

  	
   

  	 

	
   

  	
   

  	
  Name:

  
	
   

  	
   

  	
  Title:

  
	
   

  	
   

  
	
   

  	
   

  
	
   

  	
  Attest:

  
	
   

  	
   

  
	
   

  	
   

  
	
   

  	
  By:

  	
   

  
	
   

  	
   

  	
  Name:

  
	
   

  	
   

  	
  Title:

  

 

 

[Signature Page to
Warrant]

 

 

[Form Of Notice Of Exercise]

 

Date:             

 

TO:
Washington Mutual, Inc.

 

RE:
Election to Subscribe for and Purchase Common Stock

 

The undersigned, pursuant to the provisions set
forth in the attached Warrant, hereby agrees to subscribe for and purchase the
number of shares of the Common Stock set forth below covered by such Warrant.
The undersigned, in accordance with Section 3 of the Warrant, hereby
agrees to pay the aggregate Exercise Price for such shares of Common Stock in
the manner set forth below. A new warrant evidencing the remaining shares of
Common Stock covered by such Warrant, but not yet subscribed for and purchased,
should be issued in the name set forth below. If the new warrant is being
transferred, an opinion of counsel is attached hereto with respect to the
transfer of such warrant.

 

Number
of Shares of Common Stock:                            

 

Method
of Payment of Exercise Price (note if cashless exercise pursuant to Section 3(ii) of
the Warrant):                                  

 

Name
and Address of Person to be Issued New Warrant:                              

 

 

	
   

  	
  Holder:

  	
   

  
	
   

  	
   

  	
   

  
	
   

  	
  By:

  	
   

  
	
   

  	
   

  	
   

  
	
   

  	
  Name:

  	
   

  
	
   

  	
   

  	
   

  
	
   

  	
  Title:

  	
   

  

 

[Form of Notice of Exercise]

 

 

EXHIBIT
A

 

Black-Scholes Assumptions

 

For
the purpose of this Exhibit A:

 

                “Acquiror” means (A) the third party that has
entered into definitive document for a transaction, or (B) the offeror in
the event of a tender or exchange offer, which  could reasonably result in a Fundamental Change upon
consummation.

 

	
  Underlying Security Price:

  	
  ·      In the event of a merger or
  acquisition, (A) in the event of an “all cash” deal, the cash per share
  offered to the Company’s shareholders by the Acquiror; (B) in the event
  of an “all stock” deal, (1) in the event of a fixed exchange ratio transaction,
  the product of (i) the average of the Market Price of the Acquiror’s
  common stock for the ten trading day period ending on the day preceding the
  date of the Preliminary Fundamental Change and (ii) the number of
  Acquiror’s shares being offered for one share of Common Stock and (2) in
  the event of a fixed value transaction, the value offered by the Acquiror for
  one share of Common Stock; (C) in the event of a transaction
  contemplating various forms of consideration for each share of Common Stock,
  the cash portion, if any, shall be valued as clause (A) above and the
  stock portion shall be valued as clause (B) above and any other forms of
  consideration shall be valued by the Board of Directors of the Company in
  good faith, without applying any discounts to such consideration.

  
	
   

  	
   

  
	
   

  	
  ·      In the event of all other Fundamental
  Change events, the average of the Market Price of the Common Stock for the
  five trading day period beginning on the date of the Preliminary Fundamental
  Change.

  
	
   

  	
   

  
	
   

  	
  ·      In the event of an exchange for Convertible Preferred
  Stock pursuant to Section 16 of the Warrant, the average of the Market
  Price of the Common Stock for the five trading day period ending on the
  trading day prior to the date on which this Warrant and the Notice of
  Exercise are delivered to the Company.

  
	
   

  	
   

  
	
  Exercise
  Price:

  	
  The
  Exercise Price as adjusted and then in effect for the Warrant.

  

 

 

	
  Dividend
  Rate:

  	
  The Company’s annualized dividend yield as of (i) the date of the
  Preliminary Fundamental Change in the event of a Fundamental Change or
  (ii) the trading
  day prior to the date on which this Warrant and the Notice of Exercise are
  delivered to the Company in the event of an exchange for Convertible
  Preferred Stock (the “Reference Date”).

  
	
   

  	
   

  
	
  Interest
  Rate:

  	
  The
  applicable U.S. 5-year treasury note risk free rate as of the Reference Date.

  
	
   

  	
   

  
	
  Model
  Type:

  	
  Black-Scholes

  
	
   

  	
   

  
	
  Exercise
  Type:

  	
  American

  
	
   

  	
   

  
	
  Put or
  Call:

  	
  Call

  
	
   

  	
   

  
	
  Trade
  Date:

  	
  The
  Reference Date

  
	
   

  	
   

  
	
  Expiration
  Date:

  	
  Expiration
  Time

  
	
   

  	
   

  
	
  Settle
  Date:

  	
  The
  Reference Date

  
	
   

  	
   

  
	
  Exercise
  Delay:

  	
  0

  
	
   

  	
   

  
	
  Volatility:

  	
  The
  average daily volatility over the previous six months for the Common Stock as
  listed by Bloomberg L.P., as of the Reference Date

  

 

Such
valuation of the Warrant based on the Black-Scholes methodology shall not be
discounted in any way.  If the Warrantholder
disputes such Black-Scholes valuation pursuant to this  Exhibit A as calculated by the Company, the Company and the Warrantholder will
choose a mutually-agreeable firm to compute the valuation of the Warrant using
the guidelines above, and such valuation shall be final. The fees and expenses
of such firm shall be borne equally by the Company and the Warrantholder.

 

The
Company covenants that it will not close a Fundamental Change transaction or
otherwise facilitate the closing of a tender or exchange offer as referenced
above until giving the Warrantholder at least five business days to sell or
distribute the Common Stock to be received in an exchange and will cooperate
with the Warrantholder to ensure that there is an effective registration
statement available to facilitate such a sale during such five Business Day period
or an effective opportunity is provided in the case of a tender or exchange
offer as referenced above to tender such shares in to the offer.EXHIBIT 4.3

 

THE
SECURITIES REPRESENTED BY THIS INSTRUMENT HAVE NOT BEEN REGISTERED UNDER THE
SECURITIES ACT OF 1933, AS AMENDED, OR SECURITIES LAWS OF ANY STATE AND MAY NOT
BE TRANSFERRED, SOLD OR OTHERWISE DISPOSED OF EXCEPT WHILE A REGISTRATION
STATEMENT RELATING THERETO IS IN EFFECT UNDER SUCH ACT AND APPLICABLE STATE
SECURITIES LAWS OR PURSUANT TO AN EXEMPTION FROM REGISTRATION UNDER SUCH ACT OR
SUCH LAWS.

 

THE
SECURITIES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO TRANSFER AND OTHER
RESTRICTIONS SET FORTH IN A SECURITIES PURCHASE AGREEMENT, DATED AS OF APRIL 7,
2008, COPIES OF WHICH ARE ON FILE WITH THE SECRETARY OF THE ISSUER.

 

WARRANT

 

to purchase

 

[   ]

 

Shares of Common
Stock

 

dated as of [   ]

 

WASHINGTON MUTUAL, INC.

a Washington Corporation

 

Issue Date: [   ]

 

1.             Definitions. 
Unless the context otherwise requires, when used herein the following
terms shall have the meanings indicated.

 

“Affiliate” has the
meaning set forth in Section 6.10(a) of the Securities Purchase
Agreement.

 

“Applicable Price” means
the greater of (A) the greater of the Market Price per share of
outstanding Common Stock on (i) the date on which the Company issues or
sells any Common Stock other than Excluded Stock and (ii) the first date
of the announcement of such issuance or sale and (B) the Reference
Purchase Price.

 

“Appraisal Procedure”
means a procedure whereby two independent appraisers, one chosen by the Company
and one by the Warrantholder (or if there is more than one Warrantholder, a
majority in interest of Warrantholders), shall mutually agree upon the
determinations then the subject of appraisal. 
Each party shall deliver a notice to the other appointing its appraiser
within 15 days after the Appraisal Procedure is invoked.  If within 30 days after appointment of the
two appraisers they are unable to agree upon the amount in 

 

 

question, a third independent appraiser shall be
chosen within 10 days thereafter by the mutual consent of such first two
appraisers or, if such first two appraisers fail to agree upon the appointment
of a third appraiser, such appointment shall be made by the American
Arbitration Association, or any organization successor thereto, from a panel of
arbitrators having experience in the appraisal of the subject matter to be
appraised.  The decision of the third
appraiser so appointed and chosen shall be given within 30 days after the
selection of such third appraiser.  If
three appraisers shall be appointed and the determination of one appraiser is
disparate from the middle determination by more than twice the amount by which
the other determination is disparate from the middle determination, then the
determination of such appraiser shall be excluded, the remaining two
determinations shall be averaged and such average shall be binding and conclusive
on the Company and the Warrantholder; otherwise, the average of all three
determinations shall be binding and conclusive on the Company and the
Warrantholder.  The costs of conducting
any Appraisal Procedure shall be borne by the Warrantholder requesting such
Appraisal Procedure, except (A) the fees and expenses of the appraiser
appointed by the Company and any other costs incurred by the Company shall be
borne by the Company and (B) if such Appraisal Procedure shall result in a
determination that is disparate by 5% or more from the Company’s initial
determination, all costs of conducting such Appraisal Procedure shall be borne
by the Company.

 

“Beneficially Own” or “Beneficial Owner” has the meaning set
forth in Section 4.1(f) of the Securities Purchase Agreement.

 

“Board of Directors” has
the meaning set forth in Section 2.2(d) of the Securities Purchase
Agreement.

 

“Board Representative”
has the meaning set forth in Section 4.3 of the Securities Purchase
Agreement.

 

“Business Combination”
means a merger, consolidation, statutory share exchange or similar transaction
that requires adoption by the Company’s shareholders.

 

“business day”  means any day except Saturday, Sunday and
any day which shall be a legal holiday or a day on which banking institutions
in the State of New York or in the State of Washington generally are authorized
or required by law or other governmental actions to close.

 

“Common Shares” has the
meaning set forth in Section 2.

 

 “Capital Stock” means (A) with respect to any person that
is a corporation or company, any and all shares, interests, participations or
other equivalents (however designated) of capital or capital stock of such
person and (B) with respect to any person that is not a corporation or
company, any and all partnership or other equity interests of such person.

 

“Common Stock” has the
meaning given to it in the recitals of the Securities Purchase Agreement.

 

“Company” has the meaning
set forth in the preamble of the Securities Purchase Agreement.

 

 

 “Company Subsidiary” has the meaning set forth in Section 2.2(a)(2) of
the Securities Purchase Agreement.

 

“Convertible Preferred Stock”
shall have the meaning set forth in the recitals of the Securities Purchase
Agreement.

 

“Exchange Act” means the
Securities Exchange Act of 1934, as amended, or any successor statute, and the rules and
regulations promulgated thereunder.

 

“Excluded Stock” means (A) shares
of Common Stock issued by the Company as a stock dividend payable in shares of
Common Stock, or upon any subdivision or split-up of the outstanding shares of
Capital Stock in each case which is subject to Section 13(B), or upon
conversion of shares of Capital Stock (but not the issuance of such Capital
Stock which will be subject to the provisions of Section 13(A)), (B) shares
of Common Stock to be issued to employees, consultants and advisors of the
Company pursuant to options, restricted stock units or other equity-based
awards granted prior to the date of issuance of this Warrant and pursuant to
options, restricted stock units or other equity-based awards granted after the
date of issuance of this Warrant if the exercise price per share of Common
Stock on the date of such grant equals or exceeds the Market Price of a share
of Common Stock on the date of such grant and (C) shares of Common Stock
issued by the Company in connection with a dividend reinvestment, employee or
shareholder stock purchase plan.

 

“Exercise
Approvals” means the collective reference
to the Shareholder Approvals and the Regulatory Approvals.

 

“Exercise Price” means an
amount equal to the lower of (i) an amount equal to 115% of the average
Market Price of the Common Stock during the five trading days following the
public announcement of the results of the Company’s quarter ended March 31,
2008 (it being understood that if the such announcement occurs prior to the
commencement of trading on the New York Stock Exchange, the first trading day
following such announcement shall be the day of such announcement) and (ii) an
amount equal to 115% of the Reference Purchase Price; provided, that such amount shall be
reduced by $0.50 on each six-month anniversary of the date of this Warrant if
the Shareholder Approvals shall not have been obtained prior to such
anniversary, up to a maximum reduction of $2.00.

 

“Expiration Time” has the
meaning set forth in Section 3.

 

“Fundamental Change” means the occurrence of one
of the following:

 

(i) a “person” or “group”
within the meaning of Section 13(d) of the Exchange Act files a
Schedule TO or any schedule, form or report under the Exchange Act disclosing
that such person
or group has become the direct or indirect ultimate Beneficial Owner of common
equity of the Company representing more than 50% of the voting power of the
outstanding Common Stock;

 

(ii) consummation
of any consolidation or merger of the Company or similar transaction or any
sale, lease or other transfer in one transaction or a series of transactions of
all or substantially all of the consolidated assets of the Company and its
subsidiaries, taken as a whole, to any Person other than one of the Company’s
subsidiaries, in each case pursuant to which the 

 

 

Common
Stock will be converted into cash, securities or other property, other than
pursuant to a transaction in which the Persons that Beneficially Owned,
directly or indirectly, voting shares of the Company immediately prior to such
transaction Beneficially Own, directly or indirectly, voting shares
representing a majority of the total voting power of all outstanding classes of
voting shares of the continuing or surviving Person immediately after the
transaction; or

 

(iii) the Company’s
shareholders approve and adopt a plan of liquidation or dissolution of the
Company or a sale of all or substantially all of the Company’s assets.

 

 “Governmental Entities” has the meaning set forth in Section 2.2(e) of
the Securities Purchase Agreement.

 

“Group” means a group as
contemplated by Section 13(d)(3) of the Exchange Act.

 

“Securities Purchase Agreement”
means the Securities Purchase Agreement, dated as of April 7, 2008,
between the Company and the Purchasers, including all schedules and exhibits
thereto.

 

“Purchasers” has the
meaning set forth in the preamble of the Securities Purchase Agreement.

 

“Market Price” means,
with respect to a particular security, on any given day, the last reported sale
price regular way or, in case no such reported sale takes place on such day,
the average of the last closing bid and ask prices regular way, in either case
on the principal national securities exchange on which the applicable
securities are listed or admitted to trading, or if not listed or admitted to
trading on any national securities exchange, (A) the closing sale price
for such day reported by the Nasdaq Stock Market if such security is traded
over-the-counter and quoted in the Nasdaq Stock Market, or (B) if such
security is so traded, but not so quoted, the average of the closing reported
bid and ask prices of such security as reported by the Nasdaq Stock Market or
any comparable system, or (C) if such security is not listed on the Nasdaq
Stock Market or any comparable system, the average of the closing bid and ask
prices as furnished by two members of the National Association of Securities
Dealers, Inc. selected from time to time by the Company for that
purpose.  If such security is not listed
and traded in a manner that the quotations referred to above are available for
the period required hereunder, the Market Price per share of Common Stock shall
be deemed to be the fair value per share of such security as determined in good
faith by the Board of Directors.

 

“New Issuance Price” has
the meaning set forth in Section 3(A)(i).

 

“Ordinary Cash Dividends”
means a regular quarterly cash dividend out of surplus or net profits legally
available therefor (determined in accordance with generally accepted accounting
principles, consistently applied) and consistent with past practice.

 

“person”  has the meaning given to it in Section 3(a)(9) of
the Exchange Act and as used in Sections 13(d)(3) and 14(d)(2) of the
Exchange Act.

 

“Preliminary
Fundamental Change” means, with respect to the Company, (A) the
execution of definitive documentation for a transaction or (B) the
recommendation that 

 

 

shareholders tender in
response to a tender or exchange offer, that could reasonably result in a
Fundamental Change upon consummation.

 

 “Pro Rata Repurchases” means any purchase of shares of Common
Stock by the Company or any Affiliate thereof pursuant to any tender offer or
exchange offer subject to Section 13(e) of the Exchange Act, or
pursuant to any other offer available to substantially all holders of Common
Stock, whether for cash, shares of Capital Stock of the Company, other
securities of the Company, evidences of indebtedness of the Company or any
other person or any other property (including, without limitation, shares of
Capital Stock, other securities or evidences of indebtedness of a Company
Subsidiary), or any combination thereof, effected while this Warrant is
outstanding; provided, however, that “Pro Rata Repurchase” shall
not include any purchase of shares by the Company or any Affiliate thereof made
in accordance with the requirements of Rule 10b-18 as in effect under the
Exchange Act.  The “Effective Date” of a Pro Rata Repurchase
shall mean the date of acceptance of shares for purchase or exchange under any
tender or exchange offer which is a Pro Rata Repurchase or the date of purchase
with respect to any Pro Rata Repurchase that is not a tender or exchange offer.

 

“Regulatory Approvals”
with respect to the Warrantholder, means the receipt of approvals and
authorizations of, filings and registrations with, notifications to, or
expiration or termination of any applicable waiting period under, the
Hart-Scott-Rodino Antitrust Improvements Act of 1976 or the competition or
merger control laws of other jurisdictions, in each case necessary to the
extent necessary to permit such Warrantholder to exercise this Warrant for a
Share and to own such Share of Common Stock.

 

“Reference Purchase Price”
has the meaning set forth in Section 1.2(b) of the Securities
Purchase Agreement.

 

“Reset Price” has the meaning set forth in Section 3(A)(i).

 

“SEC” means the U.S.
Securities and Exchange Commission.

 

“Securities Act” means
the Securities Act of 1933, as amended, or any successor statute, and the rules and
regulations promulgated thereunder.

 

“Shares” has the meaning
set forth in Section 2.

 

“Shareholder Approvals”
means all shareholder approvals necessary to (A) approve the exercise of
this Warrant for a Share for purposes of Section 312.03 of the NYSE Listed
Company Manual, and (B) amend the Articles to increase the number of
authorized shares of Common Stock to at least such number as shall be
sufficient to permit the exercise of this Warrant for a Share.

 

 “Subsidiary” has the meaning set forth in Section 2.2(a)(2) of
the Securities Purchase Agreement.

 

“Underlying Security Price”
has the meaning set forth in Section 3(A)(i).

 

 

“Voting Securities” has
the meaning set forth in Section 4.1(f) of the Securities Purchase
Agreement.

 

“Warrantholder” has the
meaning set forth in Section 2.

 

“Warrants” means this
Warrant, issued pursuant to the Securities Purchase Agreement.

 

2.             Number of Shares; Exercise Price. 
This certifies that, for value received, [NAME OF HOLDER], its
affiliates or its registered assigns (the “Warrantholder”)
is entitled, upon the terms and subject to the conditions hereinafter set
forth, to acquire from the Company, in whole or in part, after the receipt of
Exercise Approvals, up to an aggregate of [·] fully paid and nonassessable shares of
Common Stock, no par value, of the Company (the “Common Shares”), at a
purchase price per Common Share equal to the Exercise Price.  The number of Common Shares (the “Shares”) and the Exercise Price are
subject to adjustment as provided herein, and all references to “Common Stock”
and “Exercise Price” herein shall be deemed to include any such adjustment or
series of adjustments.

 

3.             Exercise of Warrant; Term. 
Subject to Section 2, to the extent permitted by applicable laws
and regulations, the right to purchase the Shares represented by this Warrant
is exercisable, in whole or in part by the Warrantholder, at any time or from
time to time after 9:00 a.m., New York City time, on the date hereof, but
in no event later than 11:59 p.m., New York City time, on the fifth
anniversary of the date of issuance of the Warrant (the “Expiration
Time”), by (A) the surrender of this Warrant and Notice of
Exercise annexed hereto, duly completed and executed on behalf of the
Warrantholder, at the office of the Company in Seattle, Washington (or such
other office or agency of the Company in the United States as it may designate
by notice in writing to the Warrantholder at the address of the Warrantholder
appearing on the books of the Company), and (B) payment of the Exercise
Price for the Shares thereby purchased at the election of the Warrantholder in
one of the following manners:

 

(i)            by tendering in cash, by certified or
cashier’s check or by wire transfer payable to the order of the Company, or

 

(ii)           by having the Company withhold shares of Common Stock
issuable upon exercise of the Warrant equal in value to the aggregate Exercise
Price as to which this Warrant is so exercised based on the Market Price of the
Common Stock on the trading day prior to the date on which this Warrant and the
Notice of Exercise are delivered to the Company.

 

If the Warrantholder does not exercise this Warrant in
its entirety, the Warrantholder will be entitled to receive from the Company
within a reasonable time, and in any event not exceeding three business days, a
new warrant in substantially identical form for the purchase of that number of
Shares equal to the difference between the number of Shares subject to this
Warrant and the number of Shares as to which this Warrant is so exercised.
Notwithstanding anything in this Warrant to the contrary, the Warrantholder
hereby acknowledges and agrees that its exercise of this Warrant for Shares is
subject to the condition that it will have first received the Shareholder
Approvals.

 

 

4.             Issuance of Shares; Authorization;
Listing.  Certificates for Shares issued upon exercise
of this Warrant will be issued in such name or names as the Warrantholder may
designate and will be delivered to such named person or persons within a
reasonable time, not to exceed three business days after the date on which this
Warrant has been duly exercised in accordance with the terms of this
Warrant.  The Company hereby represents
and warrants that any Shares issued upon the exercise of this Warrant in
accordance with the provisions of Section 3 will, upon receipt of the
Shareholder Approvals, be duly and validly authorized and issued, fully paid
and nonassessable and free from all taxes, liens and charges (other than liens
or charges created by the Warrantholder or taxes in respect of any transfer
occurring contemporaneously therewith). 
The Company agrees that the Shares so issued will be deemed to have been
issued to the Warrantholder as of the close of business on the date on which
this Warrant and payment of the Exercise Price are delivered to the Company in
accordance with the terms of this Warrant, notwithstanding that the stock
transfer books of the Company may then be closed or certificates representing
such Shares may not be actually delivered on such date.  Subject to receipt of Exercise Approvals, the
Company will at all times reserve and keep available, out of its authorized but
unissued Common Stock, solely for the purpose of providing for the exercise of
this Warrant, the aggregate number of shares of Common Stock issuable upon
exercise of this Warrant.  The Company
will (A) procure, at its sole expense, the listing of the Shares and other
securities issuable upon exercise of this Warrant, subject to issuance or
notice of issuance on all stock exchanges on which the Common Stock are then
listed or traded and (B) maintain the listing of such Shares after
issuance.  The Company will use
reasonable best efforts to ensure that the Shares may be issued without
violation of any applicable law or regulation or of any requirement of any
securities exchange on which the Shares are listed or traded.

 

5.             No Fractional Shares or Scrip. 
No fractional Shares or scrip representing fractional Shares shall be
issued upon any exercise of this Warrant. 
In lieu of any fractional Share to which the Warrantholder would
otherwise be entitled, the Warrantholder shall be entitled to receive a cash
payment equal to the Market Price of the Common Stock less the Exercise Price
for such fractional share.

 

6.             No Rights as Shareholders; Transfer Books. 
This Warrant does not entitle the Warrantholder to any voting rights or
other rights as a shareholder of the Company prior to the date of exercise
hereof.  The Company will at no time
close its transfer books against transfer of this Warrant in any manner which
interferes with the timely exercise of this Warrant.

 

7.             Charges, Taxes and Expenses. 
Issuance of certificates for Shares to the Warrantholder upon the
exercise of this Warrant shall be made without charge to the Warrantholder for
any issue or transfer tax or other incidental expense in respect of the
issuance of such certificates, all of which taxes and expenses shall be paid by
the Company.

 

8.             Transfer/Assignment.

 

(A)          Subject to compliance with clause (B) of
this Section 8, without obtaining the consent of the Company to assign or
transfer this Warrant, this Warrant and all rights hereunder are transferable,
in whole or in part, upon the books of the Company by the registered holder
hereof in person or by duly authorized attorney, and a new warrant shall be
made and delivered by the Company, of the same tenor and date as this Warrant
but registered in the name of one or 

 

 

more transferees, upon surrender of this Warrant, duly
endorsed, to the office or agency of the Company described in Section 2.  All expenses (other than stock transfer
taxes) and other charges payable in connection with the preparation, execution
and delivery of the new warrants pursuant to this Section 8 shall be paid
by the Company.

 

(B)           Notwithstanding the foregoing, this
Warrant and any rights hereunder, and any Shares issued upon exercise of this
Warrant, shall be subject to the applicable restrictions as set forth in Section 4.2
of the Securities Purchase Agreement.

 

(C)           If and for so long as required by the
Securities Purchase Agreement, this Warrant Certificate shall contain a legend
as set forth in Section 4.4 of the Securities Purchase Agreement.

 

9.             Exchange and Registry of Warrant. 
This Warrant is exchangeable, upon the surrender hereof by the Warrantholder
to the Company, for a new warrant or warrants of like tenor and representing
the right to purchase the same aggregate number of Shares.  The Company shall maintain a registry showing
the name and address of the Warrantholder as the registered holder of this
Warrant.  This Warrant may be surrendered
for exchange or exercise, in accordance with its terms, at the office of the
Company, and the Company shall be entitled to rely in all respects, prior to
written notice to the contrary, upon such registry.

 

10.           Loss, Theft, Destruction or Mutilation of
Warrant.  Upon receipt by the Company of evidence
reasonably satisfactory to it of the loss, theft, destruction or mutilation of
this Warrant, and in the case of any such loss, theft or destruction, upon
receipt of an indemnity or security reasonably satisfactory to the Company, or,
in the case of any such mutilation, upon surrender and cancellation of this
Warrant, the Company shall make and deliver, in lieu of such lost, stolen,
destroyed or mutilated Warrant, a new Warrant of like tenor and representing
the right to purchase the same aggregate number of Shares as provided for in
such lost, stolen, destroyed or mutilated Warrant.

 

11.           Saturdays, Sundays, Holidays, etc. 
If the last or appointed day for the taking of any action or the
expiration of any right required or granted herein shall not be a business day,
then such action may be taken or such right may be exercised on the next
succeeding day that is a business day.

 

12.           Rule 144 Information. 
The Company covenants that it will use its reasonable best efforts to
timely file all reports and other documents required to be filed by it under
the Securities Act and the Exchange Act and the rules and regulations
promulgated by the SEC thereunder (or, if the Company is not required to file
such reports, it will, upon the request of any Warrantholder, make publicly
available such information as necessary to permit sales pursuant to Rule 144
or Regulation S under the Securities Act), and it will use reasonable best
efforts to take such further action as any Warrantholder may reasonably
request, in each case to the extent required from time to time to enable such
holder to sell the Warrants without registration under the Securities Act
within the limitation of the exemptions provided by (A) Rule 144 or
Regulation S under the Securities Act, as such rules may be amended from
time to time, or (B) any similar rule or regulation hereafter adopted
by the SEC.  Upon the written request of
any 

 

 

Warrantholder, the Company will deliver to such
Warrantholder a written statement that it has complied with such requirements.

 

13.           Adjustments and Other Rights. 
The Exercise Price and the number of Shares issuable upon exercise of
this Warrant shall be subject to adjustment from time to time as follows; provided that no single event shall be
subject to adjustment under more than one subsection of this Section 13 so
as to result in duplication:

 

(A)          Common Stock Issued at Less than the
Applicable Price.

 

(i)            If prior to the date that is nine months
after the date of this Warrant, (i) the Company issues or sells, or agrees
to issue or sell, more than $500 million of equity or equity-linked securities
other than Excluded Stock for consideration per share (the “New Issuance Price”) less than the
Applicable Price, or (ii) there occurs any Fundamental Change in which the
Underlying Security Price (together with the New Issuance Price, the “Reset Price”) is less than the Applicable
Price, then the Exercise Price in effect immediately prior to each such
issuance or sale will immediately be reduced to the Reset Price. In such event,
the number of Shares issuable upon the exercise of this Warrant shall be
increased to the number obtained by dividing (x) the product of (1) the
number of Shares issuable upon the exercise of this Warrant before such
adjustment and (2) the Exercise Price in effect immediately prior to the
issuance or sale giving rise to this adjustment, by (y) the new Exercise
Price determined in accordance with the immediately preceding sentence.

 

(ii)           For the purposes of any adjustment of the
Exercise Price and the number of Shares issuable upon exercise of this Warrant
pursuant to this Section 13(A), the following provisions shall be
applicable:

 

(1)           In the case of the issuance or sale of
equity or equity-linked securities for cash, the amount of the consideration
received by the Company shall be deemed to be the amount of the gross cash
proceeds received by the Company for such securities before deducting therefrom
any discounts or commissions allowed, paid or incurred by the Company for any
underwriting or otherwise in connection with the issuance and sale thereof.

 

(2)           In the case of the issuance or sale of
equity or equity-linked securities (otherwise than upon the conversion of
shares of Capital Stock or other securities of the Company) for a consideration
in whole or in part other than cash, including securities acquired in exchange
therefor (other than securities by their terms so exchangeable), the
consideration other than cash shall be deemed to be the fair value thereof as
determined by the Board of Directors, before deducting therefrom any discounts
or commissions allowed, paid or incurred by the Company for any underwriting or
otherwise in connection with the issuance and sale thereof, provided, however,
that such fair value as determined by the Board of Directors shall not exceed
the Applicable Price.

 

 

(3)           In the case of the
issuance of (i) options, warrants or other rights to purchase or acquire
equity or equity-linked securities (whether or not at the time exercisable) or (i) securities
by their terms convertible into or exchangeable for equity or equity-linked
securities (whether or not at the time so convertible or exchangeable) or
options, warrants or rights to purchase such convertible or exchangeable
securities (whether or not at the time exercisable):

 

(a)           The aggregate maximum number of
securities deliverable upon exercise of such options, warrants or other rights
to purchase or acquire equity or equity-linked securities shall be deemed to
have been issued at the time such options, warrants or rights are issued and
for a consideration equal to the consideration (determined in the manner
provided in Section 13(A)(i)), if any, received by the Company upon the
issuance or sale of such options, warrants or rights plus the minimum purchase
price provided in such options, warrants or rights for the equity or
equity-linked securities covered thereby.

 

(b)           The aggregate maximum number of
shares of equity or equity-linked securities deliverable upon conversion of or
in exchange for any such convertible or exchangeable securities, or upon the
exercise of options, warrants or other rights to purchase or acquire such
convertible or exchangeable securities and the subsequent conversion or
exchange thereof, shall be deemed to have been issued at the time such
securities were issued or such options, warrants or rights were issued and for
a consideration equal to the consideration, if any, received by the Company for
any such securities and related options, warrants or rights (excluding any cash
received on account of accrued interest or accrued dividends), plus the
additional consideration (in each case, determined in the manner provided in Section 13(A)(i) and
(ii)), if any, to be received by the Company upon the conversion or exchange of
such securities, or upon the exercise of any related options, warrants or rights
to purchase or acquire such convertible or exchangeable securities and the
subsequent conversion or exchange thereof.

 

(c)           On any change in the number of shares
of equity or equity-linked securities deliverable upon exercise of any such
options, warrants or rights or conversion or exchange of such convertible or
exchangeable securities or any change in the consideration to be received by
the Company upon such exercise, conversion or exchange, but excluding changes
resulting from the anti-dilution provisions thereof (to the extent comparable
to the anti-dilution provisions contained herein), the Exercise Price and the
number of Shares issuable upon exercise of this Warrant as then in effect shall
forthwith be readjusted to such Exercise Price and number of Shares as would
have been obtained had an adjustment been made upon the issuance or sale of
such options, warrants or rights not exercised prior to such change, or of such
convertible or exchangeable 

 

 

securities not converted
or exchanged prior to such change, upon the basis of such change.

 

(d)           On the expiration or cancellation of
any such options, warrants or rights (without exercise), or the termination of
the right to convert or exchange such convertible or exchangeable securities
(without exercise), if the Exercise Price and the number of Shares issuable
upon exercise of this Warrant shall have been adjusted upon the issuance or
sale thereof, the Exercise Price and the number of Shares issuable upon
exercise of this Warrant shall forthwith be readjusted to such Exercise Price
and number of Shares as would have been obtained had an adjustment been made
upon the issuance or sale of such options, warrants, rights or such convertible
or exchangeable securities on the basis of the issuance of only the number of
shares of Common Stock actually issued upon the exercise of such options,
warrants or rights, or upon the conversion or exchange of such convertible or
exchangeable securities.

 

(e)           If the Exercise Price and the number
of Shares issuable upon exercise of this warrant shall have been adjusted upon
the issuance or sale of any such options, warrants, rights or convertible or
exchangeable securities, no further adjustment of the Exercise Price and the
number of Shares issuable upon exercise of this Warrant shall be made for the
actual issuance of Common Stock upon the exercise, conversion or exchange
thereof; provided, however, that no increase in the Exercise
Price or reduction in the number of Shares issuable upon exercise of this
Warrant shall be made pursuant to subclauses (1) or (2) of this Section 13(A)(iii).

 

(B)           Stock
Splits, Subdivisions, Reclassifications or Combinations.  If the Company shall (i) declare a
dividend or make a distribution on its Common Stock in shares of Common Stock, (ii) subdivide
or reclassify the outstanding shares of Common Stock into a greater number of
shares, or (iii) combine or reclassify the outstanding Common Stock into a
smaller number of shares, the number of Shares issuable upon exercise of this
Warrant at the time of the record date for such dividend or distribution or the
effective date of such subdivision, combination or reclassification shall be
proportionately adjusted so that the Warrantholder after such date shall be
entitled to purchase the number of shares of Common Stock which such holder
would have owned or been entitled to receive after such date had this Warrant
been exercised immediately prior to such date. 
In such event, the Exercise Price in effect at the time of the record
date for such dividend or distribution or the effective date of such
subdivision, combination or reclassification shall be adjusted to the number
obtained by dividing (x) the product of (1) the number of Shares
issuable upon the exercise of this Warrant before such adjustment and (2) the
Exercise Price in effect immediately prior to the issuance giving rise to this
adjustment by (y) the new number of Shares issuable upon exercise of the
Warrant determined pursuant to the immediately preceding sentence.

 

(C)           Other
Distributions.  In case the Company
shall fix a record date for the making of a distribution to all holders of
shares of its Common Stock (i) of shares of any class other than 

 

 

its Common Stock, (ii) of evidence of
indebtedness of the Company or any Company Subsidiary, (iii) of assets
(excluding Ordinary Cash Dividends, and dividends or distributions referred to
in Section 13(B)), or (iv) of rights or warrants (excluding those
referred to in Section 13(B)), in each such case, the Exercise Price in
effect prior thereto shall be reduced immediately thereafter to the price
determined by dividing (x) an amount equal to the difference resulting
from (1) the number of shares of Common Stock outstanding on such record
date multiplied by the Exercise Price per Share on such record date, less (2) the
fair market value (as reasonably determined by the Board of Directors) of said
shares or evidences of indebtedness or assets or rights or warrants to be so
distributed, by (y) the number of shares of Common Stock outstanding on
such record date; such adjustment shall be made successively whenever such a
record date is fixed.  In such event, the
number of Shares issuable upon the exercise of this Warrant shall be increased
to the number obtained by dividing (x) the product of (1) the number
of Shares issuable upon the exercise of this Warrant before such adjustment,
and (2) the Exercise Price in effect immediately prior to the issuance
giving rise to this adjustment by (y) the new Exercise Price determined in
accordance with the immediately preceding sentence.  In the event that such distribution is not so
made, the Exercise Price and the number of Shares issuable upon exercise of
this Warrant then in effect shall be readjusted, effective as of the date when
the Board of Directors determines not to distribute such shares, evidences of
indebtedness, assets, rights or warrants, as the case may be, to the Exercise
Price that would then be in effect and the number of Shares that would then be
issuable upon exercise of this Warrant if such record date had not been fixed.

 

(D)          Certain
Repurchases of Common Stock.  In case
the Company effects a Pro Rata Repurchase of Common Stock, then the Exercise
Price shall be reduced to the price determined by multiplying the Exercise
Price in effect immediately prior to the effective date of such Pro Rata
Repurchase by a fraction of which the numerator shall be (i) the product
of (x) the number of shares of Common Stock outstanding immediately before
such Pro Rata Repurchase and (y) the Market Price of a share of Common
Stock on the trading day immediately preceding the first public announcement by
the Company or any of its Affiliates of the intent to effect such Pro Rata
Repurchase, minus (ii) the aggregate purchase price of the Pro Rata
Repurchase, and of which the denominator shall be the product of (i) the
number of shares of Common Stock outstanding immediately prior to such Pro Rata
Repurchase minus the number of shares of Common Stock so repurchased and (ii) the
Market Price per share of Common Stock on the trading day immediately preceding
the first public announcement of such Pro Rata Repurchase.  In such event, the number of shares of Common
Stock issuable upon the exercise of this Warrant shall be increased to the number
obtained by dividing (x) the product of (1) the number of Shares
issuable upon the exercise of this Warrant before such adjustment, and (2) the
Exercise Price in effect immediately prior to the Pro Rata Repurchase giving
rise to this adjustment by (y) the new Exercise Price determined in accordance
with the immediately preceding sentence.

 

(E)           Business
Combinations.  Subject to Section 14
of this Warrant, in case of any Business Combination or reclassification of
Common Stock (other than a reclassification of Common Stock referred to in Section 13(B)),
any Shares issued or issuable upon exercise of this Warrant after the date of
such Business Combination or reclassification, shall be exchangeable for the
number of shares of stock or other securities or property (including cash) to
which the Common Stock issuable (at the time of such Business Combination or
reclassification) upon exercise of this Warrant immediately prior to such
Business Combination or reclassification would have been entitled upon such
Business Combination or reclassification; and in any such 

 

 

case, if necessary, the provisions set forth herein
with respect to the rights and interests thereafter of the Warrantholder shall
be appropriately adjusted so as to be applicable, as nearly as may reasonably
be, to any shares of stock or other securities or property thereafter
deliverable on the exercise of this Warrant. 
In determining the kind and amount of stock, securities or the property
receivable upon consummation of such Business Combination, if the holders of
Common Stock have the right to elect the kind or amount of consideration
receivable upon consummation of such Business Combination, then the
Warrantholder shall have the right to make a similar election upon exercise of
this Warrant with respect to the number of shares of stock or other securities
or property which the Warrantholder will receive upon exercise of this Warrant.

 

(F)           Rounding
of Calculations; Minimum Adjustments. 
All calculations under this Section 13 shall be made to the nearest
one-tenth (1/10th) of a cent or to the nearest one-hundredth (1/100th) of a
share, as the case may be.  Any provision
of this Section 13 to the contrary notwithstanding, no adjustment in the
Exercise Price or the number of Shares into which this Warrant is exercisable
shall be made if the amount of such adjustment would be less than $0.01 or
one-tenth (1/10th) of a share of Common Stock, but any such amount shall be
carried forward and an adjustment with respect thereto shall be made at the
time of and together with any subsequent adjustment which, together with such
amount and any other amount or amounts so carried forward, shall aggregate
$0.01 or 1/10th of a share of Common Stock, or more.

 

(G)           Timing
of Issuance of Additional Common Stock Upon Certain Adjustments.  In any case in which the provisions of this Section 13
shall require that an adjustment shall become effective immediately after a
record date for an event, the Company may defer until the occurrence of such
event (i) issuing to the Warrantholder of this Warrant exercised after
such record date and before the occurrence of such event the additional shares
of Common Stock issuable upon such exercise by reason of the adjustment
required by such event over and above the shares of Common Stock issuable upon
such exercise before giving effect to such adjustment and (ii) paying to
such Warrantholder any amount of cash in lieu of a fractional share of Common
Stock; provided, however, that the Company upon request
shall deliver to such Warrantholder a due bill or other appropriate instrument
evidencing such Warrantholder’s right to receive such additional shares, and
such cash, upon the occurrence of the event requiring such adjustment.

 

(H)          Adjustment
for Unspecified Actions.  If the
Company takes any action affecting the Common Stock, other than actions
described in this Section 13, which in the opinion of the Board of
Directors would materially adversely affect the exercise rights of the
Warrantholder, the Exercise Price for the Warrant and/or the number of Shares
received upon exercise of the Warrant shall be adjusted for the Warrantholder’s
benefit, to the extent permitted by law, in such manner, and at such time, as
such Board of Directors after consultation with the Warrantholder shall
reasonably determine to be equitable in the circumstances.  Failure of the Board of Directors to provide
for any such adjustment will be evidence that the Board of Directors has
determined that it is equitable to make no such adjustments in the circumstances.

 

(I)            Statement
Regarding Adjustments.  Whenever the
Exercise Price or the number of Shares into which this Warrant is exercisable
shall be adjusted as provided in Section 13, the Company shall forthwith
file at the principal office of the Company a statement showing in 

 

 

reasonable detail the facts requiring such adjustment
and the Exercise Price that shall be in effect and the number of Shares into
which this Warrant shall be exercisable after such adjustment, and the Company
shall also cause a copy of such statement to be sent by mail, first class
postage prepaid, to each Warrantholder at the address appearing in the Company’s
records.

 

(J)            Notice
of Adjustment Event.  In the event
that the Company shall propose to take any action of the type described in this
Section 13 (but only if the action of the type described in this Section 13
would result in an adjustment in the Exercise Price or the number of Shares
into which this Warrant is exercisable or a change in the type of securities or
property to be delivered upon exercise of this Warrant), the Company shall give
notice to the Warrantholder, in the manner set forth in Section 13(I),
which notice shall specify the record date, if any, with respect to any such
action and the approximate date on which such action is to take place.  Such notice shall also set forth the facts
with respect thereto as shall be reasonably necessary to indicate the effect on
the Exercise Price and the number, kind or class of shares or other securities
or property which shall be deliverable upon exercise of this Warrant.  In the case of any action which would require
the fixing of a record date, such notice shall be given at least 10 days prior
to the date so fixed, and in case of all other action, such notice shall be
given at least 15 days prior to the taking of such proposed action.  Failure to give such notice, or any defect
therein, shall not affect the legality or validity of any such action.

 

(K)          No
Impairment.  The Company will not, by
amendment of its articles of incorporation or through any reorganization,
transfer of assets, consolidation, merger, dissolution, issue or sale of
securities or any other voluntary action, avoid or seek to avoid the observance
or performance of any of the terms to be observed or performed hereunder by the
Company, but will at all times in good faith assist in the carrying out of all
the provisions of this Warrant and in taking of all such action as may be
necessary or appropriate in order to protect the rights of the Warrantholder.

 

(L)           Proceedings
Prior to Any Action Requiring Adjustment. 
As a condition precedent to the taking of any action which would require
an adjustment pursuant to this Section 13, the Company shall take any
action which may be necessary, including obtaining regulatory, New York Stock
Exchange or shareholder approvals or exemptions, in order that the Company may
thereafter validly and legally issue as fully paid and nonassessable all shares
of Common Stock  that the Warrantholder
is entitled to receive upon exercise of this Warrant pursuant to this Section 13.

 

(M)         Adjustment
Rules.  Any adjustments pursuant to
this Section 13 shall be made successively whenever an event referred to
herein shall occur.  If an adjustment in
Exercise Price made hereunder would reduce the Exercise Price to an amount
below par value of the Common Stock, then such adjustment in Exercise Price
made hereunder shall reduce the Exercise Price to the par value of the Common
Stock.

 

14.           Fundamental
Change.  Upon the occurrence of a
Preliminary Fundamental Change or Fundamental Change, and by delivering written
notice thereof to the Company, the Warrantholder may cause the Company to
purchase any Warrant, in whole or in part, acquired hereunder that the
Warrantholder then holds, at the higher of (i) the fair market value of
the Warrant and (ii) a valuation based on a computation of the option
value of the Warrant using 

 

 

Black-Scholes calculation methods and making the
assumptions described in the Black-Scholes methodology described in Exhibit A.  Payment by the Company to the Warrantholder
of such purchase price shall be due upon the occurrence of the Fundamental
Change, subject to the mechanics described in the last paragraph of Exhibit A.  At the election of the Company, all or any
portion of such purchase price may be paid in cash or in Common Shares valued
at the Market Price of a share of Common Stock as of (A) the last trading
day prior to the date on which this payment occurs or (B) the first date
of the announcement of such Preliminary Fundamental Change or Fundamental
Change (whichever is less), so long as such payment does not cause either (i) the
Company to fail to comply with applicable New York Stock Exchange requirements
or the requirements of any other Governmental Entities or (ii) the
Warrantholder to own 25% or more of the Company’s outstanding Common Shares or
otherwise be in violation of the limitations set forth in 12 C.F.R. Part 574
(or any successor provision).  To the
extent that a payment in Common Shares would cause the Company to fail to
comply with New York Stock Exchange rules or result in the Warrantholder
being in violation of such limitations, once the maximum number of Common
Shares that would not result in the contravention of such rules has been
paid, the remainder of such purchase price may be paid, at the option of the
Company and provided the issuance of securities would not cause the
Warrantholder to be in violation of such limitations, in the form of cash or
equity securities of the Company having a fair market value on a
fully-distributed basis equal to the value (determined as provided above) of
the Common Shares that would have been issued to the Warrantholder in the
absence of the limitation described in this sentence.  The Company agrees that it will not take any
action resulting in a Preliminary Fundamental Change or Fundamental Change in
the absence of definitive documentation providing for such election right of
the Warrantholder pursuant to this Section 14.  The Warrantholder shall not be restricted
from engaging in any hedging or derivative program reasonably necessary in the
opinion of the Warrantholder to secure the option value of this Warrant so
adjusted.

 

15.           Exchange
for Convertible Preferred Stock.  At
any time prior to the receipt of Exercise Approvals, the Warrantholder may
cause the Company to exchange this Warrant for a number of shares of
Convertible Preferred Stock equal to the product of (i) the value of this
Warrant based on the higher of (A) the fair market value of the Warrant
and (B) a computation of the option value of the Warrant using the
Black-Scholes calculation methods and making the assumptions described in the
Black-Scholes methodology described in Exhibit A divided by (ii) the
lower of (A) $100,000 or (B) the fair market value of a share of
Convertible Preferred Stock, provided that
the Company shall pay cash to the Warrantholder in lieu of any fractional
shares of Convertible Preferred Stock. 
The Company will at all times reserve and keep available, out of its
authorized preferred stock, a sufficient number of shares of preferred stock
for the purpose of providing for the exchange of this Warrant for shares of
Convertible Preferred Stock.  The Company
shall initially calculate any fair market value required to be calculated
pursuant to Section 14 and this Section 15.  If the Warrantholder does not accept the
Company’s calculation of fair market value and the Warrantholder and the
Company are unable to agree on fair market value, the Appraisal Procedure shall
be used to determine fair market value.

 

16.           Governing
Law.  This Warrant shall be binding
upon any successors or assigns of the Company. 
This Warrant shall constitute a contract under the laws of New York and
for all purposes shall be construed in accordance with and governed by the laws
of New York, without giving effect to the conflict of laws principles.

 

 

17.           Attorneys’
Fees.  In any litigation, arbitration
or court proceeding between the Company and the Warrantholder as the holder of
this Warrant relating hereto, the prevailing party shall be entitled to reasonable
attorneys’ fees and expenses incurred in enforcing this Warrant.

 

18.           Amendments.  This Warrant may be amended and the
observance of any term of this Warrant may be waived only with the written
consent of the Company and the Warrantholder.

 

19.           Notices.  All notices hereunder shall be in writing and
shall be effective (A) on the day on which delivered if delivered
personally or transmitted by telex or telegram or telecopier with evidence of
receipt, (B) one business day after the date on which the same is
delivered to a nationally recognized overnight courier service with evidence of
receipt, or (C) five business days after the date on which the same is
deposited, postage prepaid, in the U.S. mail, sent by certified or registered
mail, return receipt requested, and addressed to the party to be notified at
the address indicated below for the Company, or at the address for the
Warrantholder set forth in the registry maintained by the Company pursuant to Section 9,
or at such other address and/or telecopy or telex number and/or to the
attention of such other person as the Company or the Warrantholder may
designate by ten-day advance written notice.

 

20.           Prohibited
Actions.  The Company agrees that it
will not take any action which would entitle the Warrantholder to an adjustment
of the Exercise Price if the total number of shares of Common Stock issuable
after such action upon exercise of this Warrant, together with all shares of
Common Stock then outstanding and all shares of Common Stock then issuable upon
the exercise of all outstanding options, warrants, conversion and other rights,
would exceed the total number of shares of Common Stock then authorized by its
articles of incorporation.

 

21.           Entire
Agreement.  This Warrant and the
forms attached hereto, and the Securities Purchase Agreement, contain the
entire agreement between the parties with respect to the subject matter hereof
and supersede all prior and contemporaneous arrangements or undertakings with
respect thereto.

 

[Remainder
of page intentionally left blank]

 

 

IN WITNESS WHEREOF, the Company has caused
this Warrant to be duly
executed by a duly authorized officer.

 

Dated:
[              ]

 

 

	
   

  	
  WASHINGTON MUTUAL, INC.

  
	
   

  	
   

  
	
   

  	
   

  
	
   

  	
  By:

  	
   

  
	
   

  	
   

  	
  Name:

  
	
   

  	
   

  	
  Title:

  
	
   

  	
   

  
	
   

  	
   

  
	
   

  	
  Attest:

  
	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  
	
   

  	
  By:

  	
   

  
	
   

  	
   

  	
  Name:

  
	
   

  	
   

  	
  Title:

  

 

 

[Signature Page to
Warrant]

 

 

[Form Of Notice Of Exercise]

 

Date:               

 

TO:
Washington Mutual, Inc.

 

RE:
Election to Subscribe for and Purchase Common Stock

 

The undersigned, pursuant to the provisions set
forth in the attached Warrant, hereby agrees to subscribe for and purchase the
number of shares of the Common Stock set forth below covered by such Warrant.
The undersigned, in accordance with Section 3 of the Warrant, hereby
agrees to pay the aggregate Exercise Price for such shares of Common Stock in
the manner set forth below. A new warrant evidencing the remaining shares of
Common Stock covered by such Warrant, but not yet subscribed for and purchased,
should be issued in the name set forth below. If the new warrant is being
transferred, an opinion of counsel is attached hereto with respect to the
transfer of such warrant.

 

Number
of Shares of Common Stock:                        

 

Method
of Payment of Exercise Price (note if cashless exercise pursuant to Section 3(ii) of
the Warrant):                    

 

Name
and Address of Person to be
Issued New Warrant:                                  

 

	
   

  	
  Holder:

  	
   

  
	
   

  	
   

  	
   

  
	
   

  	
  By:

  	
   

  
	
   

  	
   

  	
   

  
	
   

  	
  Name:

  	
   

  
	
   

  	
   

  	
   

  
	
   

  	
  Title:

  	
   

  

 

 

EXHIBIT
A

 

Black-Scholes Assumptions

 

For
the purpose of this Exhibit A:

 

“Acquiror” means (A) the third party that has entered into
definitive document for a transaction, or (B) the offeror in the event of
a tender or exchange offer, which  could reasonably result in a Fundamental Change upon
consummation.

 

	
  Underlying Security Price:

  	
  ·      In the event of a merger or
  acquisition, (A) in the event of an “all cash” deal, the cash per share
  offered to the Company’s shareholders by the Acquiror; (B) in the event
  of an “all stock” deal, (1) in the event of a fixed exchange ratio transaction,
  the product of (i) the average of the Market Price of the Acquiror’s
  common stock for the ten trading day period ending on the day preceding the
  date of the Preliminary Fundamental Change and (ii) the number of
  Acquiror’s shares being offered for one share of Common Stock and (2) in
  the event of a fixed value transaction, the value offered by the Acquiror for
  one share of Common Stock; (C) in the event of a transaction
  contemplating various forms of consideration for each share of Common Stock,
  the cash portion, if any, shall be valued as clause (A) above and the
  stock portion shall be valued as clause (B) above and any other forms of
  consideration shall be valued by the Board of Directors of the Company in
  good faith, without applying any discounts to such consideration.

  
	
   

  	
   

  
	
   

  	
  ·      In the event of all other Fundamental
  Change events, the average of the Market Price of the Common Stock for the
  five trading day period beginning on the date of the Preliminary Fundamental
  Change.

  
	
   

  	
   

  
	
   

  	
  ·      In the event of an exchange for Convertible Preferred
  Stock pursuant to Section 15 of the Warrant, the average of the Market
  Price of the Common Stock for the five trading day period ending on the
  trading day prior to the date on which this Warrant and the Notice of
  Exercise are delivered to the Company.

  
	
   

  	
   

  
	
  Exercise
  Price:

  	
  The
  Exercise Price as adjusted and then in effect for the Warrant.

  

 

 

	
  Dividend
  Rate:

  	
  The Company’s annualized dividend yield as of (i) the date of the
  Preliminary Fundamental Change in the event of a Fundamental Change or
  (ii) the trading
  day prior to the date on which this Warrant and the Notice of Exercise are
  delivered to the Company in the event of an exchange for Convertible
  Preferred Stock (the “Reference Date”).

  
	
   

  	
   

  
	
  Interest
  Rate:

  	
  The
  applicable U.S. 5-year treasury note risk free rate as of the Reference Date.

  
	
   

  	
   

  
	
  Model
  Type:

  	
  Black-Scholes

  
	
   

  	
   

  
	
  Exercise
  Type:

  	
  American

  
	
   

  	
   

  
	
  Put or
  Call:

  	
  Call

  
	
   

  	
   

  
	
  Trade
  Date:

  	
  The
  Reference Date

  
	
   

  	
   

  
	
  Expiration
  Date:

  	
  Expiration
  Time

  
	
   

  	
   

  
	
  Settle
  Date:

  	
  The
  Reference Date

  
	
   

  	
   

  
	
  Exercise
  Delay:

  	
  0

  
	
   

  	
   

  
	
  Volatility:

  	
  The
  average daily volatility over the previous six months for the Common Stock as
  listed by Bloomberg L.P., as of the Reference Date

  

 

Such
valuation of the Warrant based on the Black-Scholes methodology shall not be
discounted in any way.  If the Warrantholder
disputes such Black-Scholes valuation pursuant to this  Exhibit A as calculated by the Company, the Company and the Warrantholder will
choose a mutually-agreeable firm to compute the valuation of the Warrant using
the guidelines above, and such valuation shall be final. The fees and expenses
of such firm shall be borne equally by the Company and the Warrantholder.

 

The
Company covenants that it will not close a Fundamental Change transaction or
otherwise facilitate the closing of a tender or exchange offer as referenced
above until giving the Warrantholder at least five business days to sell or
distribute the Common Stock to be received upon exercise or in exchange
therefor and will cooperate with the Warrantholder to ensure that there is an
effective registration statement available to facilitate such a sale during
such five Business Day period or an effective opportunity is provided in the
case of a tender or exchange offer as referenced above to tender such shares in
to the offer.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00146-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00146-of-00352.parquet"}]]